FCBT
EBS icon

First Citizens Bank & Trust’s Emergent Biosolutions EBS Stock Holding History

First Citizens Bank & Trust’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-28,781
Closed -$646K – 333
2014
Q2 		$646K Buy
+28,781
New +$670K 0.06% 218

Other funds holding EBS

Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

First Citizens Bank & Trust's EBS Position: Q3 2014 in Review

First Citizens Bank & Trust sold out of Emergent Biosolutions (EBS) in Q3 2014, closing a stake of 28,781 shares — an estimated $646K sold.

First Citizens Bank & Trust first reported a position in EBS in Q2 2014 and held it in 1 quarter. The position peaked at $646K in Q2 2014. 162 funds tracked by Wall St. Rank hold EBS as of Q3 2014.

  • First Citizens Bank & Trust reported no remaining Emergent Biosolutions position as of Q3 2014 after selling out during the quarter.
  • First Citizens Bank & Trust sold 28,781 Emergent Biosolutions shares in Q3 2014, an estimated $646K.
  • First Citizens Bank & Trust first reported a position in Emergent Biosolutions in Q2 2014 and held it in 1 quarter.
  • First Citizens Bank & Trust's Emergent Biosolutions position peaked at $646K in Q2 2014.
  • 162 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2014.

Based on First Citizens Bank & Trust's 13F filing for Q3 2014, filed 8 Oct 2014.